NCT06797492

Brief Summary

Goal: The clinical investigation involves the evaluation of the usability level of the VR system, sense of presence, and co-presence during the execution of various rehabilitation exercises through specific questionnaires. Participant Population: The study will enroll 50 patients with shoulder musculoskeletal disorders will be enrolled Main Questions:

  • How does the integration of Virtual Reality (VR) in rehabilitation programs impact the usability of the system for patients with shoulder musculoskeletal disorders?
  • To what extent does the sense of presence experienced by patients using VR systems influence their motivation and adherence to rehabilitation exercises?
  • How do patients with shoulder musculoskeletal disorders perceive the co-presence in VR rehabilitation scenarios, and how does it affect their overall treatment experience? Participant Tasks:
  • Shoulder Physical Examination
  • Instructions to the patient on exercises to be performed using Oculus and selection of customizable settings on the VR app
  • Execution of the protocol developed for shoulder rehabilitation in a virtual environment
  • Evaluation of the usability of the VR system, sense of presence, and co-presence through different validated scales

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
18mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Sep 2025Dec 2027

First Submitted

Initial submission to the registry

January 22, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 4, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

January 22, 2025

Last Update Submit

March 2, 2026

Conditions

Keywords

Musculoskeletal disordersshoulder rehabilitationvirtual reality

Outcome Measures

Primary Outcomes (1)

  • Change in Usability Level of the VR System Using the System Usability Scale (SUS)

    The usability of the VR system during the execution of several rehabilitation exercises will be assessed using the System Usability Scale (SUS). The SUS is a widely used questionnaire that measures the overall usability of a system, based on a 10-item scale that assesses the ease of use, satisfaction, and functionality of the system from the user's perspective. Scores range from 0 to 100, with higher scores indicating better usability.

    Across four rehabilitation phases: T1 (0-4/6 weeks), T2 (6-12 weeks), T3 (12-20 weeks), and T4 (beyond 20 weeks)

Secondary Outcomes (2)

  • Change in Sense of Presence Using the Igroup Presence Questionnaire (IPQ)

    The sense of presence will be evaluated across four rehabilitation phases: T1 (0-4/6 weeks), T2 (6-12 weeks), T3 (12-20 weeks), and T4 (beyond 20 weeks)

  • Change in Co-Presence Using the Networked Minds Social Presence Inventory

    The co-presence will be assessed across four rehabilitation phases: T1 (0-4/6 weeks), T2 (6-12 weeks), T3 (12-20 weeks), and T4 (beyond 20 weeks).

Study Arms (1)

Patients with shoulder musculoskeletal disorders

EXPERIMENTAL

The study will involve 50 adults with shoulder musculoskeletal disorders. Eligible participants are those over 18 with significant shoulder pathologies, excluding individuals with neurological conditions, infections, inflammatory diseases, major previous shoulder surgeries, or pregnancy. After obtaining informed consent, baseline demographic and anthropometric data will be collected. Patients will be assessed by a clinician across four rehabilitation phases: T1 (0-4/6 weeks), T2 (6-12 weeks), T3 (12-20 weeks), and T4 (beyond 20 weeks). Each phase includes a shoulder examination followed by a 30-minute VR-based rehabilitation session, customized to the patient's physical characteristics.

Diagnostic Test: Shoulder Physical ExaminationProcedure: Shoulder Rehabilitation in a Virtual EnvironmentOther: Usability assessment and presence and co-presence evaluation

Interventions

shoulder physical examination is conducted to assess the patient's musculoskeletal condition and to track progress throughout the rehabilitation phases

Patients with shoulder musculoskeletal disorders

The rehabilitation protocol for shoulder disorders is executed using a Virtual Reality (VR) system, where patients perform customized exercises tailored to their physical characteristics.

Patients with shoulder musculoskeletal disorders

The usability of the VR system, along with the sense of presence and co-presence during rehabilitation, is assessed using validated scales

Patients with shoulder musculoskeletal disorders

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with shoulder musculoskeletal disorders
  • Patients aged 18-75 years
  • Patients who have signed informed consent

You may not qualify if:

  • Patients with insufficient cognitive and language functions to follow instructions provided by clinicians and/or experimenters involved in the project
  • Patients who do exhibit impediments that could hinder the use of VR devices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fondazione Policlinico Universitario Campus Bio-Medico

Roma, Italy, 00128, Italy

RECRUITING

Fondazione Policlinico Universitario Campus Bio-Medico

Rome, Italy, 00128, Italy

NOT YET RECRUITING

MeSH Terms

Conditions

Musculoskeletal Diseases

Central Study Contacts

Umile Giuseppe Longo, MD, MSc, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 22, 2025

First Posted

January 28, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

March 4, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The ownership of the data is of the promoter and shared with the investigators and will be managed according to the agreements between the participating institutions and with the researchers. Data Property belongs to Fondazione Policlinico Universitario Campus Bio-Medico. The personnel involved in this study will have access to all data. In agreement with the ICH-GCP, the principal investigator of the study agrees to produce a report on the study, share all the data collected as described in the Protocol, and ensure that the data are reported responsibly and consistently. The transmission or dissemination of data through scientific publications and/or presentations in congresses, conferences, seminars, and participation in multicenter studies will take place exclusively following a purely statistical processing of the same, or in any case, in an anonymous form.

Locations